DILTIAZEM HYDROCHLORIDE INJECTION Solution

Pays: Canada

Langue: français

Source: Health Canada

Ingrédients actifs:

Chlorhydrate de diltiazem

Disponible depuis:

STRIDES PHARMA CANADA INC

Code ATC:

C08DB01

DCI (Dénomination commune internationale):

DILTIAZEM

Dosage:

5MG

forme pharmaceutique:

Solution

Composition:

Chlorhydrate de diltiazem 5MG

Mode d'administration:

Intraveineuse

Unités en paquet:

100

Type d'ordonnance:

Prescription

Domaine thérapeutique:

MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS

Descriptif du produit:

Numéro de groupe d'ingrédients actifs (GIA) :0115863003; AHFS:

Statut de autorisation:

APPROUVÉ

Date de l'autorisation:

2020-05-01

Résumé des caractéristiques du produit

0212*5 3,( '( 352',
3U
ORU GUDHGH GLOLD HP LQMHF DEOH
ORU GUDH GH GLOLD HP LQMHF DEOH
ROXLRQSRXUDGPLQLVUDLRQLQ UDYHLQHXVH
PJP/, 9
Q LDU
PLTXH
DYULO
'DWHGHUpYLVLRQ
1
R
GH FRQWUOH GHODSUpVHQWDWLRQ
&DQDGD - ;3
9DUHQQHV 4XHEHF
%RXO/LRQHO
%RXOHW
6WULGHV 3KDUPD &DQDGD,QF
0212*53,('( 352',
3U
ORU
GUDHGH'LO LDHP ,QMHFDEOH
ORU
GUD HGH'LO LDHP ,QMHFDEOH
ROX LRQSRXU DGPLQLVUDLRQLQUDYHLQHXVH
PJ PO,9
/(e5 3( ,4(
Q LDU
PLTXH
02'( '
,21(
3502/2*,(/,1,4(
/HFKORUK GUDWH GH GLOWLD]HP LQMHFWDEOH HVWXQ LQKLELWHXUGH O
LQIOX[GHVLRQVFDOFLTXHV
LQKLELWHXU GXFDQDO
FDOFLTXH RX DQWDJRQLVWHGX FDQDOFDOFLTXH
0RGHGDFLRQ
/HFKORUK GUDWH GHGLOWLD]HPLQMHFWDEOHLQKLEH OHPRXYHPHQW GHV LRQV
FDOFLXP GXUDQW ODGpSRODULVDWLRQGH
OD PHPEUDQHFHOOXODLUHGXPXVFOHFDUGLDTXH HW GXPXVFOH OLVVHGHVYDLVVHDX[
/HVELHQIDLWVWKpUDSHXWLTXHV
GXGLOWLD]HP GDQVOHWUDLWHPHQW GHV WDFK FDUGLHV VXSUDYHQWULFXODLUHV
SURYLHQQHQW GHVDFDSDFLWpGH UDOHQWLU
OD FRQGXFWLRQHW GH SURORQJHUODSpULRGH UpIUDFWDLUHGDQVOHQ°XG
DXULFXORYHQWULFXODLUH
9
/HV HIIHWV GX
GLOWLD]HP VXU OD FRQGXFWLRQ GDQV OH Q°XG
9 GpSHQGHQW GH OD IUpTXHQFH
GH O XWLOLVDWLRQ
DXVVL FH
PpGLFDPHQW SHXW LO UpGXLUH VpOHFWLYHPHQW OD IUpTXHQFH FDUGLDTXH GXUDQW
OHV WDFKFDUGLHV DVVRFLpHV DX
Q°XG
9 WRXW HQ QHQWUDvQDQWTXH SHX RX SDVGHIIHWV VXU OD
FRQGXFWLRQGDQVOHQ°XG
9 DX[IUpTXHQFHV
QRUPDOHV
/H GLOWLD]HP UDOHQWLW
OD IUpTXHQFH YHQWULFXODLUH FKH] OHV SDWLHQWV FKH] TXL
OD UpSRQVH YHQWULFXODLUH HVW
UDSLGH GXUDQW ODILEULOODWLRQRXOHIOXWWHUDXULFXODLUH /H
GLOWLD]HPUpWDEOLW OHUWKPHVLQXVDOQRUPDOGDQVOHV
WDFK FDUGLHV SDUR[VWLTXHV VXSUDYHQWULFXODLUHV
7693 HQ LQWHUURPSDQW OD UpHQWUpH GDQVOHVWDFKFDUGLHV
QRGDOHV GHUpHQWUpH HW GDQV OHVWDFKFDUGLHV UpFLSURTXHV FRPPH OHV QGURPH
GH :ROII 3DUNLQVRQ :KLWH
:3:
/HGLOWLD]HP SURORQJHOH FFOHVLQXVDO,OQ D DXFXQHIIHWVXUOH WHPSV
GHUpFXSpUDWLRQ GX Q°XG VLQXVDOQL
VXU OH WHPSV GH FRQGXFWLRQ VLQR DXULFXODLUH
6 HQ O DEVHQFH GH GVIRQFWLRQQHPHQW GX Q°XG 6 /H
GLOWLD]HP Q HQWUDvQH SDV GHIIHWpOHFWURSKVLRORJLTXH LPSRUWDQW
VXU OHVWLVVXV GX F°XU TXL GpSHQGHQW GHV
FDQDX[ VRGLTXHV UDSLGHV
FRPPH OH IDLVFHDX GH +LV OH UpVHDX GH 3X